{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T02:18:37Z","timestamp":1778206717220,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"National Research Foundation of South Africa","award":["79484"],"award-info":[{"award-number":["79484"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1906-3","type":"journal-article","created":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T06:59:34Z","timestamp":1477465174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa"],"prefix":"10.1186","volume":"16","author":[{"given":"Navisha","family":"Dookie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Willem","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashini","family":"Moodley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,26]]},"reference":[{"key":"1906_CR1","unstructured":"World Health Organization. Global tuberculosis report. Geneva: World Health Organization; 2014. [ http:\/\/apps.who.int\/iris\/bitstream\/10665\/191102\/1\/9789241565059_eng.pdf ]. Accessed 25 Oct 2016."},{"key":"1906_CR2","unstructured":"National Department of Health South Africa. National Tuberculosis Treatment Guidelines. 2014. [ http:\/\/www.nicd.ac.za\/assets\/files\/Acrobat%20Document2.pdf ]. Accessed 25 Oct 2016."},{"key":"1906_CR3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijid.2015.01.014","volume":"32","author":"JD Fonseca","year":"2015","unstructured":"Fonseca JD, Knight GM, McHugh TD. The complex evolution of antibiotic resistance in Mycobacterium tuberculosis. Int J Infect Dis. 2015;32:94\u2013100.","journal-title":"Int J Infect Dis"},{"key":"1906_CR4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/10158782.2013.11441547","volume":"28","author":"N Ismail","year":"2013","unstructured":"Ismail N, Koornof H. Tuberculosis continues to be a public health problem in South Africa from diagnosis to treatment. South African J Epidemiol Infect. 2013;28:191.","journal-title":"South African J Epidemiol Infect"},{"key":"1906_CR5","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/jac\/dkr173","volume":"66","author":"PEA Silva Da","year":"2011","unstructured":"Da Silva PEA, Palomino JC. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: Classical and new drugs. J Antimicrob Chemother. 2011;66:1417\u201330.","journal-title":"J Antimicrob Chemother"},{"key":"1906_CR6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/antibiotics3030317","volume":"3","author":"JC Palomino","year":"2014","unstructured":"Palomino JC, Martin A. Drug Resistance Mechanisms in Mycobacterium tuberculosis. Antibiotics. 2014;3:317\u201340.","journal-title":"Antibiotics"},{"issue":"11","key":"1906_CR7","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.5588\/ijtld.15.0389","volume":"19","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Yew W-W. Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015. Int J Tuberc Lung Dis. 2015;19(11):1276\u201389.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1906_CR8","doi-asserted-by":"publisher","unstructured":"Cohen KA, Abeel T, Manson McGuire A, Desjardins CA, Munsamy V, Shea TP, et al.: Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal. PLoS Med, 12(9):e1001880. doi: 10.1371\/journal.pmed.1001880 .","DOI":"10.1371\/journal.pmed.1001880"},{"key":"1906_CR9","volume-title":"Clinical Microbiology Procedures Handbook: Susceptibility tests by modified agar Proportion","author":"H Isenberg","year":"2004","unstructured":"Isenberg H. Clinical Microbiology Procedures Handbook: Susceptibility tests by modified agar Proportion. 2004."},{"key":"1906_CR10","unstructured":"World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. Geneva: World Health Organization; 2009. [ http:\/\/apps.who.int\/iris\/bitstream\/10665\/44206\/1\/9789241598675_eng.pdf ]. Accessed 25 Oct 2016."},{"key":"1906_CR11","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/JCM.29.11.2578-2586.1991","volume":"29","author":"D Soolingen Van","year":"1991","unstructured":"Van Soolingen D, Hermans PWM, De Haas PEW, Soll DR, Van Embden JDA. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: Evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol. 1991;29:2578\u201386.","journal-title":"J Clin Microbiol"},{"key":"1906_CR12","unstructured":"Rozen, S and Skaletsky H. Primer 3 Software V4.0. 2009. [ http:\/\/bioinfo.ut.ee\/primer3-0.4.0\/primer3\/ ]. Accessed 25 Oct 2016."},{"key":"1906_CR13","unstructured":"Drummond AJ, Ashton B. Geneious Software version 5.5.7. 2011. [ http:\/\/www.geneious.com\/download ]. Accessed 25 Oct 2016."},{"key":"1906_CR14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/JCM.31.2.406-409.1993","volume":"31","author":"JDA Embden Van","year":"1993","unstructured":"Van Embden JDA, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Hermans P, Martin C, McAdam R, Shinnick TM, Small PM. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: Recommendations for a standardized methodology. J Clin Microbiol. 1993;31:406\u20139.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"1906_CR15","doi-asserted-by":"crossref","first-page":"e0132076","DOI":"10.1371\/journal.pone.0132076","volume":"10","author":"JR Lim","year":"2015","unstructured":"Lim JR, Gandhi NR, Mthiyane T, Mlisana K, Moodley J, Jaglal L, Ramdin N, Brust JCM, Ismail N, Rustomjee R, Shah NS. Incidence and Geographic Distribution of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa. PLoS One. 2015;10(7):e0132076.","journal-title":"PLoS One"},{"key":"1906_CR16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1371\/journal.pone.0007778","volume":"4","author":"TR Ioerger","year":"2009","unstructured":"Ioerger TR, Koo S, No EG, Chen X, Larsen MH, Jacobs WR, Pillay M, Sturm AW, Sacchettini JC. Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa. PLoS One. 2009;4:2\u201311.","journal-title":"PLoS One"},{"key":"1906_CR17","volume":"7","author":"D Machado","year":"2012","unstructured":"Machado D, Couto I, Perdig\u00e3o J, Rodrigues L, Portugal I, Baptista P, Veigas B, Amaral L, Viveiros M. Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis. PLoS One. 2012;7:e34538.","journal-title":"PLoS One."},{"key":"1906_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.MGM2-0023-2013","volume":"2","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Shi W, Zhang W, Mitchison D. Mechanisms of Pyrazinamide Action and Resistance. Microbiol Spectrum. 2014;2:1\u201312.","journal-title":"Microbiol Spectrum"},{"key":"1906_CR19","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1128\/JB.186.13.4051-4055.2004","volume":"186","author":"O Zimhony","year":"2004","unstructured":"Zimhony O, Vilche C, Jacobs WR. Characterization of Mycobacterium smegmatis Expressing the Mycobacterium tuberculosis Fatty Acid Synthase I (fas1) Gene. J Bacteriol. 2004;186:4051\u20135.","journal-title":"J Bacteriol"},{"issue":"9","key":"1906_CR20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073230","volume":"8","author":"SA Joosten","year":"2013","unstructured":"Joosten SA, Fletcher HA, Ottenhoff THM. A Helicopter Perspective on TB Biomarkers: Pathway and process based analysis of gene expression data provides new insight into TB Pathogenesis. PLoS One. 2013;8(9):e73230.","journal-title":"PLoS One"},{"key":"1906_CR21","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/AAC.06126-11","volume":"56","author":"AH Diacon","year":"2012","unstructured":"Diacon AH, Donald PR, Pym A, Grobusch M, Patientia RF, Mahanyele R, Bantubani N, Narasimooloo R, De Marez T. Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis : Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance. Antimicrob Agents Chemother. 2012;56:3271\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"1906_CR22","first-page":"81","volume":"9","author":"PM Kelly","year":"2005","unstructured":"Kelly PM, Lumb R, Pinto A, Costa G, Sarmento J, Bastian I. Analysis of Mycobacterium tuberculosis isolates from treatment failure patients living in East Timor. Int J Tuberc Lung Dis. 2005;9:81\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1906_CR23","first-page":"167","volume":"10","author":"PM Kelly","year":"2005","unstructured":"Kelly PM, Ardian M, Waramori G, Anstey NM, Syahrial H, Tjitra E, Bastian I, Maguire GP, Lumb R. A community-based TB drug susceptibility study in Mimika District, Papua Province, Indonesia. 2006. Int J Tuberc Lung Dis. 2005;10:167\u201371.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1906_CR24","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1128\/JCM.00973-08","volume":"46","author":"M Mphahlele","year":"2008","unstructured":"Mphahlele M, Syre H, Valvatne H, Stavrum R, Manns\u00e5ker T, Muthivhi T, Weyer K, Fourie PB, Grewal HMS. Pyrazinamide Resistance among South African Multidrug-Resistant Mycobacterium tuberculosis Isolates. J Clin Microbiol. 2008;46:3459\u201364.","journal-title":"J Clin Microbiol"},{"key":"1906_CR25","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1089\/mdr.2008.0798","volume":"14","author":"J Perdig\u00e3o","year":"2008","unstructured":"Perdig\u00e3o J, Macedo R, Fernandes E, Brum L, Portugal I. Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiologic perspective. Microb Drug Resist. 2008;14:2008.","journal-title":"Microb Drug Resist"},{"issue":"7","key":"1906_CR26","doi-asserted-by":"crossref","first-page":"e0133869","DOI":"10.1371\/journal.pone.0133869","volume":"10","author":"MG Whitfield","year":"2015","unstructured":"Whitfield MG, Soeters HM, Warren RM, York T. A Global Perspective on Pyrazinamide Resistance : Systematic Review and Meta- Analysis. PLoS One. 2015;10(7):e0133869.","journal-title":"PLoS One"},{"key":"1906_CR27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/thorax.57.6.477","volume":"57","author":"T Djuretic","year":"2002","unstructured":"Djuretic T, Herbert J, Drobniewski F, Yates M, Smith EG, Magee JG, Williams R, Flanagan P, Watt B, Rayner A, Crowe M, Chadwick MV, Middleton AM, Watson JM. Antibiotic resistant tuberculosis in the United Kingdom: 1993\u20131999. Thorax. 2002;57:477\u201382.","journal-title":"Thorax"},{"key":"1906_CR28","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1128\/AAC.00433-09","volume":"53","author":"MH Yu","year":"2009","unstructured":"Yu MH, Sun YJ, Wong SY, Lee ASG. Contribution of dfrA and inhA mutations to the detection of isoniazid-resistant Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother. 2009;53:4010\u20132.","journal-title":"Antimicrob Agents Chemother"},{"key":"1906_CR29","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1128\/AAC.40.9.2187","volume":"40","author":"HJ Marttila","year":"1996","unstructured":"Marttila HJ, Soini H, Huovinen P, Viljanen MK. katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients. Antimicrob Agents Chemother. 1996;40:2187\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"1906_CR30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/S0950268801006744","volume":"128","author":"T Endoh","year":"2002","unstructured":"Endoh T, Yagihashi A, Uehara N, Kobayashi D, Tsuji N, Nakamura M, Hayashi S, Fujii N, Watanabe N. Pyrazinamide resistance associated with pncA gene mutation in Mycobacterium tuberculosis in Japan. Epidemiol Infect. 2002;128:337\u201342.","journal-title":"Epidemiol Infect"},{"key":"1906_CR31","doi-asserted-by":"crossref","first-page":"O361","DOI":"10.1111\/1469-0691.12415","volume":"20","author":"CC Naidoo","year":"2014","unstructured":"Naidoo CC, Pillay M. Increased in vitro fitness of multi- and extensively drug-resistant F15\/LAM4\/KZN strains of Mycobacterium tuberculosis. Clin Microbiol Infect. 2014;20:O361\u20139.","journal-title":"Clin Microbiol Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1906-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T23:05:06Z","timestamp":1601161506000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1906-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,26]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1906"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1906-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,26]]},"article-number":"609"}}